VEGFA and cholangiocarcinoma: We have reported earlier that both EGFR and VEGF overexpressions are associated with progression of cholangiocarcinoma (Yoshikawa et al, 2008), and hypothesised that simultaneously blocking the EGFR and VEGF pathways might have synergistic therapeutic effects against cholangiocarcinoma.